Serum-dependent enhancement of Coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells

Journal of Molecular Biology

Volumn 425, Issue 24, 2013, Pages 5020-5031

  Alidjinou, Enagnon Kazali ^a   Sané, Famara ^a   Engelmann, Ilka ^a   Hober, Didier ^a  

^a University Lille   (France)

Author keywords

cytokines; Enterovirus; immunoglobulin G; in vitro; inflammation

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INOCULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; VIRUS INACTIVATION; VIRUS LOAD;

COXSACKIEVIRUS; ENTEROVIRUS;

EID: 84887988839     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.10.008     Document Type: Article

References (30)

1. D. Hober, and P. Sauter Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host Nat Rev Endocrinol 6 2010 279 289
2. H. Jaïdane, and D. Hober Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes Diabetes Metab 34 2008 537 548
3. D. Fairweather, K.A. Stafford, and Y.K. Sung Update on coxsackievirus B3 myocarditis Curr Opin Rheumatol 24 2012 401 407
4. D. Hober, and F. Sane Enteroviral pathogenesis of type 1 diabetes Discov Med 10 2010 151 160
5. W.C.G. Yeung, W.D. Rawlinson, and M.E. Craig Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies BMJ 342 2011 d35
6. D. Hober, and F. Sane Enteroviruses and type 1 diabetes BMJ 342 2011 c7072
7. H. Jaïdane, P. Sauter, F. Sane, A. Goffard, J. Gharbi, and D. Hober Enteroviruses and type 1 diabetes: towards a better understanding of the relationship Rev Med Virol 20 2010 265 280
8. M.J. Richer, and M.S. Horwitz Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes Autoimmun Rev 8 2009 611 615
9. M.Y. Donath, J. Størling, L.A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen Cytokines and beta-cell biology: from concept to clinical translation Endocr Rev 29 2008 334 350
10. S. Nair, K.C. Leung, W.D. Rawlinson, Z. Naing, and M.E. Craig Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells J Med Virol 82 2010 1950 1957
11. K. Triantafilou, and M. Triantafilou Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4 J Virol 78 2004 11313 11320
12. A. Henke, C. Mohr, H. Sprenger, C. Graebner, A. Stelzner, and M. Nain Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes J Immunol 148 1992 2270 2277
13. G.R. Vreugdenhil, P.G. Wijnands, M.G. Netea, J.W. van der Meer, W.J. Melchers, and J.M. Galama Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes Cytokine 12 2000 1793 1796
14. C.C. Kemball, M. Alirezaei, and J.L. Whitton Type B coxsackieviruses and their interactions with the innate and adaptive immune systems Future Microbiol 5 2010 1329 1347
15. M.J. Richer, D.J. Lavallée, I. Shanina, and M.S. Horwitz Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection PLoS One 4 2009 e4127
16. A.M. Milstone, J. Petrella, M.D. Sanchez, M. Mahmud, J.C. Whitbeck, and J.M. Bergelson Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate J Virol 79 2005 655 660
17. P. Sauter, and D. Hober Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases Microbes Infect 11 2009 443 451
18. S.B. Halstead, S. Mahalingam, M.A. Marovich, S. Ubol, and D.M. Mosser Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes Lancet Infect Dis 10 2010 712 722
19. A. Takada, and Y. Kawaoka Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications Rev Med Virol 13 2003 387 398
20. D. Hober, W. Chehadeh, A. Bouzidi, and P. Wattré Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis J Infect Dis 184 2001 1098 1108
21. D. Hober, W. Chehadeh, J. Weill, C. Hober, M.C. Vantyghem, and P. Gronnier Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes J Gen Virol 83 2002 2169 2176
22. W. Chehadeh, A. Bouzidi, G. Alm, P. Wattré, and D. Hober Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro J Gen Virol 82 2001 1899 1907
23. D. Hober, L. Shen, S. Benyoucef, D. De Groote, V. Deubel, and P. Wattré Enhanced TNF alpha production by monocytic-like cells exposed to dengue virus antigens Immunol Lett 53 1996 115 120
24. P. Hofmann, M. Schmidtke, A. Stelzner, and D. Gemsa Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection J Med Virol 64 2001 487 498
25. W.X. Khong, D.G.W. Foo, S.L. Trasti, E.L. Tan, and S. Alonso Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model J Virol 85 2011 3067 3076
26. W. Chehadeh, P.E. Lobert, P. Sauter, A. Goffard, B. Lucas, and J. Weill Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon J Virol 79 2005 13882 13891
27. P. Sauter, P.E. Lobert, B. Lucas, R. Varela-Calvino, G. Alm, and P. Wattre Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells Virus Res 125 2007 183 190
28. P. Sauter, W. Chehadeh, P.E. Lobert, M. Lazrek, A. Goffard, and M. Soumillon A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes J Med Virol 80 2008 866 878
29. J.F. Han, R.Y. Cao, Y.Q. Deng, X. Tian, T. Jiang, and E.D. Qin Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo Virol J 8 2011 106
30. A.K. Berg, A. Olsson, O. Korsgren, and G. Frisk Antiviral treatment of Coxsackie B virus infection in human pancreatic islets Antiviral Res 74 2007 65 71